Evidence map›Paper›PMID 30185667›Full record

ArticleJCI insight2018

Mouse model of Gram-negative prosthetic joint infection reveals therapeutic targets.

John M Thompson, Robert J Miller, Alyssa G Ashbaugh, Carly A Dillen, Julie E Pickett, Yu Wang, Roger V Ortines, Robert S Sterling, Kevin P Francis, Nicholas M Bernthal and 8 more

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Effect of sonication on staphylococcal and gram-negative biofilms relevant to prosthetic joint infections: an in vitro study.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2026
    Article
  5. Article
  6. MappingMicroorganisms · 2024
    Article
  7. Article
  8. Article
  9. Development of an anti-Frontiers in cellular and infection microbiology · 2023
    Article
  10. Article
  11. Article
  12. CCR2 contributes to host defense against Staphylococcus aureus orthopedic implant-associated infections in mice.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2022
    Article
  13. Development of an innovativeFrontiers in medicine · 2022
    Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Functionalization of Synthetic Bone Substitutes.International journal of molecular sciences · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 2 institutions in 1 country.

John M ThompsonDepartment of Orthopaedic Surgery.
Robert J MillerDepartment of Dermatology, and.
Alyssa G AshbaughDepartment of Dermatology, and.
Carly A DillenDepartment of Dermatology, and.
Julie E PickettDepartment of Radiology and Radiological Sciences, Division of Nuclear Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Yu WangDepartment of Dermatology, and.
Roger V OrtinesDepartment of Dermatology, and.
Robert S SterlingDepartment of Orthopaedic Surgery.
Kevin P FrancisPerkinElmer, Hopkinton, Massachusetts, USA.
Nicholas M BernthalDepartment of Orthopaedic Surgery, David Geffen School of Medicine at UCLA, Santa Monica, California, USA.
Taylor S CohenDepartment of Infectious Diseases and.
Christine TkaczykDepartment of Infectious Diseases and.
Li YuStatistical Sciences, MedImmune, Gaithersburg, Maryland, USA.
C Kendall StoverDepartment of Infectious Diseases and.
Antonio DiGiandomenicoDepartment of Infectious Diseases and.
Bret R SellmanDepartment of Infectious Diseases and.
Daniel Lj ThorekDepartment of Radiology and Radiological Sciences, Division of Nuclear Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Lloyd S MillerDepartment of Orthopaedic Surgery.
Johns Hopkins University · USPerkinElmer (United States) · US

Funding

Training In Orthopaedic Team ScienceT32AR067708 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI JONES, LYNNE C., SHAFIQ, BABAR · 2015 to 2024
$2.0M
IL-36 responses in Staphylococcus aureus driven skin inflammationR01AR073665 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI ARCHER, NATHAN K. · 2018 to 2022
$1.8M
STAT3-mediated immunity to Staphylococcus aureus in skinR01AR069502 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI ARCHER, NATHAN K. · 2016 to 2020
$1.8M
Modifying and Delivering Antimicrobials to Prevent Orthopaedic Implant InfectionsK08AR069112 · NIAMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BERNTHAL, NICHOLAS M. · 2016 to 2019
$704k
NIAMS NIH HHS K08 AR069112NIAMS NIH HHS R01 AR069502NIAMS NIH HHS R01 AR073665NIAMS NIH HHS T32 AR067708
6 · The paper itself

Abstract

Bacterial biofilm infections of implantable medical devices decrease the effectiveness of antibiotics, creating difficult-to-treat chronic infections. Prosthetic joint infections (PJI) are particularly problematic because they require prolonged antibiotic courses and reoperations to remove and replace the infected prostheses. Current models to study PJI focus on Gram-positive bacteria, but Gram-negative PJI (GN-PJI) are increasingly common and are often more difficult to treat, with worse clinical outcomes. Herein, we sought to develop a mouse model of GN-PJI to investigate the pathogenesis of these infections and identify potential therapeutic targets. An orthopedic-grade titanium implant was surgically placed in the femurs of mice, followed by infection of the knee joint with Pseudomonas aeruginosa or Escherichia coli. We found that in vitro biofilm-producing activity was associated with the development of an in vivo orthopedic implant infection characterized by bacterial infection of the bone/joint tissue, biofilm formation on the implants, reactive bone changes, and inflammatory immune cell infiltrates. In addition, a bispecific antibody targeting P. aeruginosa virulence factors (PcrV and Psl exopolysaccharide) reduced the bacterial burden in vivo. Taken together, our findings provide a preclinical model of GN-PJI and suggest the therapeutic potential of targeting biofilm-associated antigens.

Indexed as

AnimalsAnti-Bacterial AgentsAntigens, BacterialBacterial ToxinsBiofilmsDisease Models, AnimalEscherichia coliFemurGram-Negative BacteriaGram-Negative Bacterial InfectionsInflammationKnee JointMaleMiceMice, Inbred C57BLOrthopedicsAnti-Bacterial AgentsAntigens, Bacterialantigen V, PseudomonasBacterial ToxinsPore Forming Cytotoxic ProteinsTitaniumVirulence FactorsBacterial infectionsInfectious diseaseMouse modelsTherapeutics

Identifiers

PMID30185667
PMCPMC6171808
OpenAlexW2890468953

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.